UP Innovation Days 2025

6 – 7 May 2025 | Pécs, Hungary

Hetényi Roland

CEO

RoLink Biotechnology Kft.

Pécs, Hungary

4 profile visits

Medical doctor who realised how to scale up UV inactivation for Rapid Response. Protein and PCR intact virus for next-gen vaccines, diagnostics, and biodefense.

My organisation

RoLink Biotechnology is a Hungarian startup founded by two young medical doctors of the National Laboratory of Virology transforming pandemic preparedness with a proprietary UV-inactivation technology that renders viruses non-infectious while preserving 100% of their structure. This enables safer, faster, and more cost-effective R&D, diagnostics, and vaccine development—cutting OPEX by up to 90%. Operating in the same team and partnership with Central Europe’s only university-based BSL-4 lab, RoLink combines startup agility with top-tier infrastructure. Integrated into EDF rapid response programs, RoLink is led by founders Dr. Roland Hetényi and Dr. Dániel Hanna (former medical school classmates) experts in virology, and vaccine development, and purification, successful history of clinical study, backed by an ex-BCG consultant, an IP expert, and national biodefense experts.
Read more

About me

Dr. Roland Hetényi, CEO of RoLink Biotechnology and strategic partner of the University of Pécs National Laboratory of Virology, will present how next-generation virus inactivation technologies can strengthen European biosecurity, biodefense, and pandemic preparedness capabilities. The talk will focus on RoLink’s UV-C inactivation platform, which is designed to eliminate viral infectivity while preserving native viral proteins and structural integrity — turning dangerous pathogens into safe, high-value materials for PCR, ELISA, vaccine development, training, and field validation applications.

The presentation will also highlight how such platforms can reduce dependence on BSL-3 and BSL-4 laboratories, accelerate rapid-response vaccine and diagnostic development, and support deployable biodefense solutions for future biological threats, including “Disease X” scenarios.

Social media

Marketplace (2)

  • Investment

    ART OF THE KILL: Rapid Response UV inactivation

    Art of the Kill: UV inactivation for Rapid Response. Protein and PCR intact virus for next-gen vaccines, diagnostics, and biodefense.

    • Healthcare
    • Seed and Development
    • Biotech, Pharma and Cosmetics
    Author

    Hetényi Roland

    CEO at RoLink Biotechnology Kft.

    Pécs, Hungary

  • Service

    Whole virion purification

    Recovery of 70%+ RNA and infective virions 99% removal of cytotoxic proteins and debris 30 minute benchtop protocol, no ultracentrifugation

    • Consulting
    • Development
    • Biotech and Lifescience
    Author

    Hetényi Roland

    CEO at RoLink Biotechnology Kft.

    Pécs, Hungary